Cerebral hemorrhage in Fabry's disease

Journal of Human Genetics

Volumn 55, Issue 4, 2010, Pages 259-261

  Nakamura, Katsuya ^a   Sekijima, Yoshiki ^a,b   Nakamura, Kimitoshi ^c   Hattori, Kiyoko ^c   Nagamatsu, Kiyoshiro ^a   Shimizu, Yusaku ^d   Yasude, Takuji ^a,d,e   Ushiyama, Masao ^f   Endo, Fumio ^c   Fukushima, Yoshimitsu ^b   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d Ina Central Hospital   (Japan)

^e Hokushin General Hospital   (Japan)

^f Kenwakai Hospital   (Japan)

Author keywords

galactosidase A; Cerebral hemorrhage; Cerebral infarction; Fabry's disease; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; GLYCOSPHINGOLIPID;

ADULT; AGED; AGING; ARTICLE; BRAIN ARTERY; BRAIN HEMORRHAGE; BRAIN INFARCTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FABRY DISEASE; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HYPERTENSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

AGED; AGED, 80 AND OVER; ALPHA-GALACTOSIDASE; CEREBRAL HEMORRHAGE; FABRY DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION;

EID: 77951711903     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.18     Document Type: Article

References (21)

1. Brady, R. O. & Schiffmann, R. Clinical features of and recent advances in therapy for Fabry disease. JAMA 284, 2771-2775 (2000).
2. Mitsias, P. & Levine, S. R. Cerebrovascular complications of Fabry's disease. Ann. Neurol. 40, 8-17 (1996).
3. MacDermot, K. D., Holmes, A. & Miners, A. H. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. JAMA 38, 750-760 (2001). (Pubitemid 33032930)
4. Grewal, R. P. Stroke in Fabry's disease. J. Neurol. 241, 153-156 (1994).
5. Buechner, S., Moretti, M., Burlina, A. P., Cei, G., Manara, R., Ricci, R. et al. Central nervous systeminvolvement in Anderson Fabry disease: a clinical and MRI retrospective study. J. Neurol. Neurosurg. Psychiatry. 79, 1249-1254 (2008).
6. Crutchfield, K. E., Patronas, N. J., Dambrosia, J. M., Frei, K. P., Banerjee, T. K., Barton, N. W. et al. Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology. 50, 1746-1749 (1998).
7. Nakao, S., Kodama, C., Takenaka, T., Tanaka, A., Yasumoto, Y., Yoshida, A. et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a 'renal variant' phenotype. Kidney Int. 64, 801-807 (2003).
8. Nakao, S., Takenaka, T., Maeda, M., Kodama, C., Tanaka, A., Tahara, M. et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N. Engl. J. Med. 333, 288-293 (1995).
9. Rolfs, A., Bottcher, T., Zschiesche, M., Morris, P., Winchester, B. & Bauer, P. et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet. 366, 1794-1796 (2005).
10. Schiffmann, R. & Ries, M. Fabry's disease-an important risk factor for stroke. Lancet. 366, 1754-1756 (2005).
11. Moore, D. F., Ye, F., Schiffmann, R. & Butman, J. A. Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am. J. Neuroradiol. 24, 1096-1101 (2003).
12. Chamoles, N. A., Blanco, M. & Gaggioli, D. Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin. Chim. Acta. 308, 195-196 (2001). (Pubitemid 32537628)
13. Bass, B. H. Angiokeratoma corporis diffusum. Br. Med. J. 1, 1418 (1958).
14. Wise, D., Jellinek, E. H. & Wallace, H. J. Angiokeratoma corporis diffusum. A clinical study of eight affected families. Q. J. Med. 31, 177-206 (1962).
15. Steward, V. W. & Hitchcock, C. Fabry's disease (angiokeratoma corporis diffusum). A report of 5 cases with pain in the extremities as the chief symptom. Pathol. Eur. 3, 377-388 (1968).
16. Yoshitama, T., Nakao, S., Takenaka, T., Teraguchi, H., Sasaki, T., Kodama, C. et al. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease. Am. J. Cardiol. 87, 71-75 (2001).
17. Sims, K., Politei, J., Banikazemi, M. & Lee, P. Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke. 40, 788-794 (2009).
18. Maisey, D. N. & Cosh, J. A. Basilar artery aneurysm and Anderson-Fabry disease. J. Neurol. Neurosurg. Psychiatry. 43, 85-87 (1980).
19. Sakuishi, K., Hashimoto, A., Ugawa, Y. & Tuji, S. An experience of enzyme therapy on adult-onset atypical Fabry's disease. Shinkeinaika. 62, 62-69 (2005). (in Japanese).
20. Moore, D. F., Kaneski, C. R., Askari, H. & Schiffmann, R. The cerebral vasculopathy of Fabry disease. J. Neurol. Sci. 257, 258-263 (2007).
21. Moore, D. F., Altarescu, G., Ling, G. S. F., Jeffries, N., Frei, K. P., Weibel, T. et al. Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement. Stroke. 33, 525-531 (2002).